US stock market experienced a downward trend on Thursday, with both the Nasdaq Composite and the S&P 500 indices falling by ...

Moderna Inc. closed $128.33 short of its 52-week high ($170.47), which the company reached on May 24th.

CAMBRIDGE, MA / ACCESSWIRE / November 12, 2024 / Moderna, Inc. (NASDAQ:MRNA) today announced it was ranked the number one large employer in ...

It's been a sad week for Moderna, Inc. (NASDAQ:MRNA), who've watched their investment drop 14% to US$46.83 in the week since the company reported its third-quarter result. In addition to smashing ...

Stephane Bancel is stepping down as chief commercial officer of Moderna Inc., according to a person familiar with the matter.

Income Tax: $8 million for the third quarter. Earnings Per Share: $0.03 for the quarter. Moderna Inc (NASDAQ:MRNA) reported $1.9 billion in revenue for the third quarter, with a net income of $13 ...

Shares of Moderna Inc. MRNA shed 6.86% to $46.83 Friday, on what proved to be an all-around favorable trading session for the ...

Moderna Inc. delivered better-than-expected profit and sales in the third quarter after an early start to sales of this ...

Heading into Moderna’s third-quarter earnings, investors and analysts will be watching to see how the Cambridge drugmaker ...

Leerink Partners analyst Mani Foroohar assigned a Sell rating on Moderna (MRNA – Research Report) on November 7 and set a price target of ...

Moderna Inc. delivered better-than-expected profit and sales in the third quarter after an early start to sales of this season’s Covid boosters. The company’s latest Covid shot was approved ...

The Cambridge, Massachusetts-based company said it had profit of 3 cents per share. The results surpassed Wall Street expectations. The average estimate of 12 analysts surveyed by Zacks Investment ...